SPHK1 and Alzheimer disease: We also confirmed that neuronal SphK1 levels are reduced in AD brain, and that increased SphK1 promoted SPM secretion in neurons, especially 15R-LXA4, by acetylating serine residue 565 (S565) of COX2, resulting in improvement of AD-like pathology.